Orchestra BioMed (Nasdaq:OBIO) expects to receive up to $21 million in cash as a result of Haemonetics' recent.

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report ...

BOSTON, June 18, 2024 /PRNewswire/ -- Haemonetics Corporation (HAE), a global medical technology company focused on delivering innovative solutions to drive better patient outcomes, has launched a ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

In the latest quarter, 5 analysts provided ratings for Haemonetics (NYSE:HAE), showcasing a mix of bullish and bearish perspectives. The following table provides a quick overview of their recent ...

The purchase is expected to expand Haemonetics’ impact in fast-growing markets for structural heart and endovascular procedures.

Haemonetics (NYSE:HAE) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below provides a concise overview of ...

Haemonetics Corporation (NYSE: HAE) on Friday said it will acquire Ireland-based Vivasure Medical Limited, a move aimed at strengthening its position in structural heart and endovascular procedures, ...

BOSTON, Oct. 9, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish second quarter fiscal year 2026 financial results at 6:00 am ET on Thursday, ...